Literature DB >> 2454393

Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1.

S O Freytag1.   

Abstract

A broad base of data has implicated a role for the c-myc proto-oncogene in the control of the cell cycle and cell differentiation. To further define the role of myc in these processes, I examined the effect of enforced myc expression on several events that are thought to be important steps leading to the terminally differentiated state: (i) the ability to arrest growth in G0/G1, (ii) the ability to replicate the genome upon initiation of the differentiation program, and (iii) the ability to lose responsiveness to mitogens and withdraw from the cell cycle. 3T3-L1 preadipocyte cell lines expressing various levels of myc mRNA were established by transfection with a recombinant myc gene under the transcriptional control of the Rous sarcoma virus (RSV) promoter. Cells that expressed high constitutive levels of pRSVmyc mRNA arrested in G0/G1 at densities similar to those of normal cells at confluence. Upon initiation of the differentiation program, such cells traversed the cell cycle with kinetics similar to those of normal cells and subsequently arrested in G0/G1. Thus, enforced expression of myc had no effect on the ability of cells to arrest growth in G0/G1 or to replicate the genome upon initiation of the differentiation program. Cells were then tested for their ability to reenter the cell cycle upon exposure to high concentrations of serum and for their capacity to differentiate. In contrast to normal cells, cells expressing high constitutive levels of myc RNA reentered the cell cycle when challenged with 30% serum and failed to terminally differentiate. The block to differentiation could be reversed by high expression of myc antisense RNA, showing that the induced block was specifically due to enforced expression of pRSVmyc. These findings indicate that 3T3-L1 preadipocytes enter a specific state in G0/G1 after treatment with differentiation inducers, into which cells expressing high constitutive levels of myc RNA are precluded from entering. I propose that myc acts as a molecular switch and directs cells to a pathway that can lead to continued proliferation or to terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454393      PMCID: PMC363321          DOI: 10.1128/mcb.8.4.1614-1624.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA.

Authors:  J G Izant; H Weintraub
Journal:  Science       Date:  1985-07-26       Impact factor: 47.728

2.  c-myc gene is transcribed at high rate in G0-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors.

Authors:  J M Blanchard; M Piechaczyk; C Dani; J C Chambard; A Franchi; J Pouyssegur; P Jeanteur
Journal:  Nature       Date:  1985 Oct 3-9       Impact factor: 49.962

3.  Evidence for an increase in transcription of specific mRNAs during differentiation of 3T3-L1 preadipocytes.

Authors:  D A Bernlohr; M A Bolanowski; T J Kelly; M D Lane
Journal:  J Biol Chem       Date:  1985-05-10       Impact factor: 5.157

4.  Molecular cloning of a cDNA for human pyruvate carboxylase. Structural relationship to other biotin-containing carboxylases and regulation of mRNA content in differentiating preadipocytes.

Authors:  S O Freytag; K J Collier
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

5.  Microinjected c-myc as a competence factor.

Authors:  L Kaczmarek; J K Hyland; R Watt; M Rosenberg; R Baserga
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

6.  Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNA.

Authors:  S K Kim; B J Wold
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

7.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

Authors:  T A Stewart; P K Pattengale; P Leder
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

8.  Levels of c-myc oncogene mRNA are invariant throughout the cell cycle.

Authors:  C B Thompson; P B Challoner; P E Neiman; M Groudine
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

9.  Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9.

Authors:  C Dony; M Kessel; P Gruss
Journal:  Nature       Date:  1985 Oct 17-23       Impact factor: 49.962

10.  c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells.

Authors:  S R Hann; C B Thompson; R N Eisenman
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

View more
  61 in total

1.  Mad1 function is regulated through elements within the carboxy terminus.

Authors:  G Barrera-Hernandez; C M Cultraro; S Pianetti; S Segal
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells.

Authors:  E J Fox; S C Wright
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

3.  Metaplastic change in mesenchymal stem cells induced by activated ras oncogene.

Authors:  C Y Tzen; M Filipak; R E Scott
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

4.  Transcriptional suppression of cellular gene expression by c-Myc.

Authors:  B S Yang; T J Geddes; R J Pogulis; B de Crombrugghe; S O Freytag
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

5.  Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development.

Authors:  E M Coccia; C Cicala; A Charlesworth; C Ciccarelli; G B Rossi; L Philipson; V Sorrentino
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

6.  Enhanced c-myc gene expression during forelimb regenerative outgrowth in the young Xenopus laevis.

Authors:  J Géraudie; J Hourdry; S Vriz; M Singer; M Méchali
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

7.  Differential effect of 6-ethylmercaptopurine on c-myc expression in wild-type and HGPRT-deficient HL-60 cells.

Authors:  B T French; D E Patrick; M R Grever; R W Trewyn
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.

Authors:  E A Musgrove; C S Lee; R L Sutherland
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

9.  AP4 encodes a c-MYC-inducible repressor of p21.

Authors:  Peter Jung; Antje Menssen; Doris Mayr; Heiko Hermeking
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

10.  Inhibition of cell proliferation by the Mad1 transcriptional repressor.

Authors:  M F Roussel; R A Ashmun; C J Sherr; R N Eisenman; D E Ayer
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.